COVID-19 and diabetes: What does the clinician need to know?
- PMID: 32654982
- PMCID: PMC7332931
- DOI: 10.1016/j.pcd.2020.06.010
COVID-19 and diabetes: What does the clinician need to know?
Abstract
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with diabetes and COVID-19.
Keywords: COVID-19; Diabetes mellitus; SARS-CoV-2.
Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
Comment in
-
COVID-19 and steroid therapy: Impact on diabetes.Prim Care Diabetes. 2020 Oct;14(5):568. doi: 10.1016/j.pcd.2020.07.013. Epub 2020 Jul 30. Prim Care Diabetes. 2020. PMID: 32778507 Free PMC article. No abstract available.
-
Newly diagnosed diabetes in COVID-19 patients.Prim Care Diabetes. 2021 Feb;15(1):194. doi: 10.1016/j.pcd.2020.08.014. Epub 2020 Aug 27. Prim Care Diabetes. 2021. PMID: 32900656 Free PMC article. No abstract available.
-
Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.Prim Care Diabetes. 2021 Feb;15(1):30. doi: 10.1016/j.pcd.2020.10.010. Epub 2020 Nov 2. Prim Care Diabetes. 2021. PMID: 33162350 Free PMC article. No abstract available.
References
-
- Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., Tang C.L., Wang T., Chen P.Y., Xiang J., Li S.Y., Wang J.L., Liang Z.J., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y., Zhong N.S. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
